CHC Healthcare Group (4164) - Total Assets
Based on the latest financial reports, CHC Healthcare Group (4164) holds total assets worth NT$14.83 Billion TWD (≈ $467.38 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is CHC Healthcare Group's book value for net asset value and shareholders' equity analysis.
CHC Healthcare Group - Total Assets Trend (2009–2024)
This chart illustrates how CHC Healthcare Group's total assets have evolved over time, based on quarterly financial data.
CHC Healthcare Group - Asset Composition Analysis
Current Asset Composition (December 2024)
CHC Healthcare Group's total assets of NT$14.83 Billion consist of 33.5% current assets and 66.5% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 11.6% |
| Accounts Receivable | NT$1.31 Billion | 9.2% |
| Inventory | NT$883.78 Million | 6.2% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$341.44 Million | 2.4% |
| Goodwill | NT$381.61 Million | 2.7% |
Asset Composition Trend (2009–2024)
This chart illustrates how CHC Healthcare Group's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CHC Healthcare Group (4164) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CHC Healthcare Group's current assets represent 33.5% of total assets in 2024, a decrease from 36.2% in 2009.
- Cash Position: Cash and equivalents constituted 11.6% of total assets in 2024, up from 7.0% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 0.0% in 2009.
- Asset Diversification: The largest asset category is accounts receivable at 9.2% of total assets.
CHC Healthcare Group Competitors by Total Assets
Key competitors of CHC Healthcare Group based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥21.18 Billion |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
CHC Healthcare Group - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.17 | 1.52 | 3.31 |
| Quick Ratio | 1.68 | 1.26 | 3.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$2.62 Billion | NT$1.45 Billion | NT$2.43 Billion |
CHC Healthcare Group - Advanced Valuation Insights
This section examines the relationship between CHC Healthcare Group's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.86 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 4.4% |
| Total Assets | NT$14.21 Billion |
| Market Capitalization | $178.76 Million USD |
Valuation Analysis
Below Book Valuation: The market values CHC Healthcare Group's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: CHC Healthcare Group's assets grew by 4.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for CHC Healthcare Group (2009–2024)
The table below shows the annual total assets of CHC Healthcare Group from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$14.21 Billion ≈ $447.83 Million |
+4.41% |
| 2023-12-31 | NT$13.61 Billion ≈ $428.90 Million |
+6.10% |
| 2022-12-31 | NT$12.83 Billion ≈ $404.24 Million |
+2.10% |
| 2021-12-31 | NT$12.57 Billion ≈ $395.94 Million |
+8.87% |
| 2020-12-31 | NT$11.54 Billion ≈ $363.69 Million |
+3.02% |
| 2019-12-31 | NT$11.21 Billion ≈ $353.03 Million |
+3.30% |
| 2018-12-31 | NT$10.85 Billion ≈ $341.76 Million |
+2.41% |
| 2017-12-31 | NT$10.59 Billion ≈ $333.74 Million |
+8.27% |
| 2016-12-31 | NT$9.78 Billion ≈ $308.23 Million |
-1.25% |
| 2015-12-31 | NT$9.91 Billion ≈ $312.13 Million |
+30.16% |
| 2014-12-31 | NT$7.61 Billion ≈ $239.80 Million |
+10.72% |
| 2013-12-31 | NT$6.87 Billion ≈ $216.58 Million |
+2.98% |
| 2012-12-31 | NT$6.68 Billion ≈ $210.31 Million |
+22.56% |
| 2011-12-31 | NT$5.45 Billion ≈ $171.59 Million |
+40.46% |
| 2010-12-31 | NT$3.88 Billion ≈ $122.16 Million |
+40.81% |
| 2009-12-31 | NT$2.75 Billion ≈ $86.76 Million |
-- |
About CHC Healthcare Group
CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitatio… Read more